of course it’s affected.. I’m not sure how anyone could argue against that, it’s honestly bleedingly obvious. You can’t manufacture one, you can’t manufacture the other. Yes keep talking to JC, keep telling you everything is alright, what else is he going to say.
The science coming out of Yale looks good so far but delay after delay is hurting. If you don’t think big pharma do their due diligence and care about being able to manufacture the drug then.. well.. I give up.
Ann: Appendix 4C - Quarterly - 31 March 2023, page-65
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2053666 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3325244 | 5 |
View Market Depth
| Last trade - 16.12pm 19/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable